patent/CN-105101967-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105101967-A

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2808f5779912ea7fdb826981e34ce015
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D223-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
filingDate	2013-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82d0085be801eb642ff36894fb587605 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdf1db953d3e1ea116c01f56a5a12f62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74539a28a23acbc1db22dc535973d93f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf128d7fad8e49a8c684b5f5d99f20e7
publicationDate	2015-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	CN-105101967-A
titleOfInvention	Benzazepine as Serotonin 5-HT2C Receptor Ligand and Its Application
abstract	The present invention generally relates to a series of compounds, pharmaceutical compositions comprising the compounds, and the use of the compounds and compositions as therapeutic agents. More specifically, the compounds of the invention are benzazepine compounds. These compounds are serotonin receptor (5-HT 2c ) ligands and are useful in the treatment of diseases, disorders and conditions in which modulation of serotonin receptor (5-HT 2c ) activity is desired (e.g., addiction, anxiety, depression, obesity and others).
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105859536-A
priorityDate	2012-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102482292-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0234760-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5512562-A
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428583188 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76684441 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467365743 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428583168 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467077333 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76684446

Total number of triples: 38.